Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Similar documents
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Carbapenemase-Producing Enterobacteriaceae (CPE)

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Other Enterobacteriaceae

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Two (II) Upon signature

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Infection Prevention and Control Policy

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

Antimicrobial resistance (EARS-Net)

Summary of the latest data on antibiotic resistance in the European Union

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Multi-Drug Resistant Organisms (MDRO)

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

Summary of the latest data on antibiotic consumption in the European Union

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Infection control: Need for robust guidelines

Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Summary of the latest data on antibiotic consumption in the European Union

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Version Control Sheet

ALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Prevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy

Dissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters

The challenge of growing resistance

2015 Antimicrobial Susceptibility Report

Infection Control of Emerging Diseases

Rise of the Superbugs: the end of antibiotics? Peter Lambert Life and Health Sciences Aston University

Antimicrobial Cycling. Donald E Low University of Toronto

Enterobacter aerogenes

Overview of Infection Control and Prevention

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Antibiotic resistance: how did we get here and what can we do? Peter Lambert LHS

Role of the nurse in diagnosing infection: The right sample, every time

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and

Antimicrobial Stewardship

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Current Trends in Antimicrobial Resistance and Need for Antimicrobial Stewardship Among Urologists. Edward A. Stenehjem, MD

Antimicrobial resistance and antimicrobial consumption in Europe

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

Surveillance of AMR in PHE: a multidisciplinary,

Antibiotic resistance: the rise of the superbugs

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Stratégie et action européennes

Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae

Practical application of antibiotic use data. Uga Dumpis MD PhD Pauls Stradins Clinical University Hospital University of Latvia

CONTAGIOUS COMMENTS Department of Epidemiology

9.5 Antimicrobial Resistance

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Dr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust

Multi-drug resistant microorganisms

9.4 Antimicrobial Resistance

Summary COMITÉ SUR LES INFECTIONS NOSOCOMIALES DU QUÉBEC. February 2018

WHO Surgical Site Infection Prevention Guidelines. Web Appendix 4

RCH antibiotic susceptibility data

How is Ireland performing on antibiotic prescribing?

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

Epidemiology and Economics of Antibiotic Resistance

EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.

Hospital Acquired Infections in the Era of Antimicrobial Resistance

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

AMR epidemiological situation: ECDC update

Intrinsic, implied and default resistance

Resistant Gram-negative Bacteria

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Healthcare Facilities and Healthcare Professionals. Public

Antimicrobial Susceptibility Testing: Advanced Course

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Controlling MRSA in the healthcare setting An achievable goal?

ESBL Positive E. coli and K. pneumoneae are Emerging as Major Pathogens for Urinary Tract Infection

Cipro for klebsiella uti

EVOLUTION OF THE ENDOGEN FLORA SUSCEPTIBILITY PROFILES AMONG MEDICAL STUDENTS IN ACCORDANCE WITH THEIR YEAR OF STUDY

APIC CHAPTER PRESENTATION 7/2014

Horizontal vs Vertical Infection Control Strategies

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Transcription:

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

CRE Enterobacteriaceae (Gram Negative Bacilli) Citrobacter species Escherichia coli*** Klebsiella species*** Morganella species Proteus species Serratia marcescens Enterobacter species Carbapenem Last line antibiotic used to treat multi drug resistant bacteria Carbapenemaise producing Bacteria that produce an enzyme that inactivates Carbapenem antibiotics

Spread in Europe 2013-2015

Consumption varies widely between countries Note: graph represents per capita consumption 10. Goossens et al.clin Infect Dis 2007; 44(8):1091-1095

CRE Infections associated with crude mortality rates of 44-70%. 7% of K. pneumoniae BSIs reported to the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2014 were carbapenem- resistant Endemic in Europe (apart from Iceland), India, North and South America

Not Just in Healthcare Via the faecal-oral route (foodborne or waterborne transmission) Hospital sewage in China, Spain and Brazil Regular sewage on Barbados River water in Portugal Retail chicken meat in Egypt Fresh vegetables and spices imported from Asia.

Normal Flora These bacteria are part of the normal flora of the gut While in the gut no problem however once they get into the blood stream, wound, urinary tract limited/ no treatment options So what? Promiscuous bacteria Happy to share genetic codes and therefore enable other bacteria to produce the enzyme Deadly superbug CRE, kills two in Melbourne, spreads across Victoria, infecting 60 June 17, 2015 11:07am Herald Sun

CPE in Victoria In Victoria since 2012, KPC-producing Klebsiella pneumoniae isolates have increased. Epidemiological data and genomic analysis of clusters indicate local transmission. Healthcare-associated spread has occurred genomic clusters have a strong or exclusive relationship with specific health service Ongoing community transmission has not been recognised CPE are not believed to be endemic in Victoria Vital to introduce proactive measures to prevent, detect and contain CPE. 2015 first case of hospital transmission in Victoria.

Risk Factors of Acquiring CRE Risk factors considered to be associated with an increased risk of becoming colonised with CPE are: Hospital stay within the previous 12 months in an area with documented or suspected CPE e.g. an overseas country or transmission risk area Prolonged hospital stay Multiple or recent exposures to different antibiotic agents including extended-spectrum penicillins, cephalosporins, fluoroquinolones and carbapenems Diabetes mellitus Indwelling medical device such as a central venous catheter, urinary catheter, biliary catheter or wound drain Organ or stem-cell transplant Admission to the intensive care unit Mechanical ventilation Poor functional status RING ANY ALARM BELLS???

Pre-emptive Isolation and Screening (PRIS) 1. Faecal specimen 2. Rectal swab & inguinal swab Contact precautions and screening are always required on admission to a Victorian health service Includes: Direct transfer from an overseas hospital Overnight stay in an overseas hospital or residential care facility in previous 12 months A room contact of a CPE case who has not achieved criteria for being cleared A ward contact of a CPE case from a transmission risk area who has not achieved criteria for being cleared

How did we get here? Poor Prescribing Gentamycin for IDC Surgical Prophylaxis for over 24 hours Treatment of asymptomatic UTI s Just in case No pathology Orthopaedic Dictionary heart \härt\ noun: pump for keflin.

What can we do? Minimise the need for antibiotics and reduce the spread of bacteria by: Getting the basics right Aseptic technique Hand hygiene Clean environment Clean equipment Invasive device management Review antibiotics at a clinical level Be proactive!

Thank you, Any questions?